Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Asset Writedowns and Impairment (2023 - 2026)

Usana Health Sciences (USNA) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $4.6 million as the latest value for Q1 2026.

  • Quarterly Asset Writedowns and Impairment rose 227500.0% to $4.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Jan 2026, up 268.43% year-over-year, with the annual reading at $7.0 million for FY2026, 268.43% up from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 was $4.6 million at Usana Health Sciences, up from $370000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $4.6 million in Q1 2026, with the low at -$506000.0 in Q4 2023.
  • Average Asset Writedowns and Impairment over 4 years is $954916.7, with a median of $500500.0 recorded in 2023.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 59.11% in 2024, then soared 227500.0% in 2026.
  • Over 4 years, Asset Writedowns and Impairment stood at -$506000.0 in 2023, then soared by 100.4% to $2000.0 in 2024, then soared by 18400.0% to $370000.0 in 2025, then surged by 1130.27% to $4.6 million in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $4.6 million, $370000.0, and $834000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.